Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancerShipeng Gong, Fei Wu|Oncotarget|2017Cited by 45
Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via <scp>cAMP</scp>/<scp>PKA</scp>/<scp>CREB</scp>‐FtMt signalling axisShipeng Gong, Fei Wu|Cell Proliferation|2018Cited by 28